Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. OMCL

Market Cap: $1.49B

OI

Omnicell, Inc.

OMCL
NASDAQUSD
Purchase OMCL
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin44.77%
EBITDA Margin8.51%
EBIT Margin5.05%
Pre-tax Margin4.90%
Net Profit Margin3.13%
Earnings Yield2.62%
Valuation Multiples
Price / Book1.15
Price / Sales1.20
Price / Earnings38.36
PEG0.55
Forward PEG-4.87
EV / Sales1.12
EV / EBITDA13.19
EV / Operating Cash Flow7.66
EV / Free Cash Flow9.89
Price / Free Cash Flow10.55
Price / Operating Cash Flow8.16
Cash Flow & Capital
Free Cash Flow / Share$3.11
Operating Cash Flow / Share$4.02
Free Cash Flow Yield9.48%
Capex / Revenue3.31%
Capex / Operating Cash Flow22.59%
Capex / Depreciation0.50
Stock Compensation / Revenue2.64%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio1.64
Quick Ratio1.43
Cash Ratio0.65
Debt / Assets0.10
Debt / Capital0.13
Debt / Equity0.15
Long-Term Debt / Capital0.12
Debt / Market Cap11.28%
Net Debt / EBITDA-0.87
Solvency Ratio0.12
Financial Leverage1.55
Efficiency & Working Capital
Asset Turnover0.62
Fixed Asset Turnover8.69
Inventory Turnover7.12
Receivables Turnover5.49
Payables Turnover13.83
Days Sales Outstanding66.47
Days Inventory Outstanding51.27
Days Payables Outstanding26.39
Operating Cycle117.74
Cash Conversion Cycle91.36
Working Capital Turnover4.73
Returns & Quality
Return on Equity3.13%
Return on Assets1.96%
Return on Invested Capital2.41%
ROCE3.80%
Return on Tangible Assets3.73%
Operating Return on Assets2.95%
Income Quality4.67
Tax Burden0.64
Interest Burden0.97
Balance Sheet & Intrinsic Metrics
Enterprise Value$1.4B
Invested Capital$1.38B
Working Capital$287.95M
Tangible Asset Value$341.66M
Net Current Asset Value$28.13M
Graham Number$23.44
Graham Net-Net-$3.99
Book Value / Share$28.41
Tangible Book Value / Share$7.51
Cash / Share$6.75
Financial Health Scores
Piotroski Score8
Altman Z-Score2.44
Revenue$1.25B
EBIT$62.92M
Market Cap$1.47B
Working Capital$287.95M
Retained Earnings$420.59M
Total Assets$2B
Total Liabilities$707.25M